APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mesalazine

This report study Mesalamine API market, Mesalamine API is off white to creamish colored powder. Mesalazine was approved for medical use in the United States in 1987.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

This report study Mesalamine API market, Mesalamine API is off white to creamish colored powder. Mesalazine was approved for medical use in the United States in 1987.

Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

Selected research

Market Outlook & Growth Opportunities

Global Mesalazine Market Outlook and Growth Opportunities 2026

31 December 2025192 pages

Choose your research edition.

Industry ResearchMesalazine Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Mesalazine Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Mesalazine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mesalazine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Mesalazine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

This report study Mesalamine API market, Mesalamine API is off white to creamish colored powder. Mesalazine was approved for medical use in the United States in 1987.

Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

The industry's leading manufacturers are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. In terms of regions, the revenue share in Europe is the highest, reaching 43% in 2021, followed by Asia Pacific with a share about 31%.

Read the full market overview

This report provides an overview of the global Mesalazine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mesalazine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mesalazine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mesalazine market size, projected growth trends, production technologies, key applications, and end-use industries.

Mesalazine Segment by Company

PharmaZell

Syntese A/S

Cambrex Corporation

Divis Laboratories

Chemi SpA

Ipca Laboratories

Hangzhou Brother

Lianyungang Fengheng Biopharm

Lasa Loboratory

Corden Pharma Bergamo

Erregierre SpA

CTX Lifescience

Ishita Active Pharma Ingredients

YC Biotech (Jiangsu)

Xinxiang Tianfeng Fine Chemical

Mesalazine Segment by Purity

Above 97 %

Above 98 %

Above 99 %

Mesalazine Segment by Application

Tablets

Capsules

Pellet and Granule

Suppository

Enema

Others

Mesalazine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Mesalazine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Mesalazine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Mesalazine significant trends, drivers, influence factors in global and regions.

6. To analyze Mesalazine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesalazine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mesalazine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesalazine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mesalazine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mesalazine industry.

Chapter 3: Detailed analysis of Mesalazine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Mesalazine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Mesalazine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Mesalazine Industry Trends Table 2. Mesalazine Industry Drivers Table 3. Mesalazine Industry Opportunities and Challenges Table 4. Mesalazine Industry Restraints Table 5. Global Mesalazine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Mesalazine Revenue Share by Company (2021-2026) Table 7. Global Mesalazine Sales Volume by Company (Ton) & (2021-2026) Table 8. Global Mesalazine Sales Volume Share by Company (2021-2026) Table 9. Global Mesalazine Average Price (US$/Kg) of Company (2021-2026) Table 10. Global Mesalazine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Mesalazine Key Company Manufacturing Base & Headquarters Table 12. Global Mesalazine Company, Product Type & Application Table 13. Global Mesalazine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Mesalazine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Above 97 % Table 18. Significant Companies of Above 98 % Table 19. Significant Companies of Above 99 % Table 20. Global Mesalazine Sales Volume by Type 2021 VS 2025 VS 2032 (Ton) Table 21. Global Mesalazine Sales Volume by Type (2021-2026) & (Ton) Table 22. Global Mesalazine Sales Volume by Type (2027-2032) & (Ton) Table 23. Global Mesalazine Sales Volume Share by Type (2021-2026) Table 24. Global Mesalazine Sales Volume Share by Type (2027-2032) Table 25. Global Mesalazine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Mesalazine Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Mesalazine Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Mesalazine Sales Value Share by Type (2021-2026) Table 29. Global Mesalazine Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Tablets Table 31. Significant Companies of Capsules Table 32. Significant Companies of Pellet and Granule Table 33. Significant Companies of Suppository Table 34. Significant Companies of Enema Table 35. Significant Companies of Others Table 36. Global Mesalazine Sales Volume by Application 2021 VS 2025 VS 2032 (Ton) Table 37. Global Mesalazine Sales Volume by Application (2021-2026) & (Ton) Table 38. Global Mesalazine Sales Volume by Application (2027-2032) & (Ton) Table 39. Global Mesalazine Sales Volume Share by Application (2021-2026) Table 40. Global Mesalazine Sales Volume Share by Application (2027-2032) Table 41. Global Mesalazine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Mesalazine Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Mesalazine Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Mesalazine Sales Value Share by Application (2021-2026) Table 45. Global Mesalazine Sales Value Share by Application (2027-2032) Table 46. Global Mesalazine Sales by Region: 2021 VS 2025 VS 2032 (Ton) Table 47. Global Mesalazine Sales by Region (2021-2026) & (Ton) Table 48. Global Mesalazine Sales Market Share by Region (2021-2026) Table 49. Global Mesalazine Sales by Region (2027-2032) & (Ton) Table 50. Global Mesalazine Sales Market Share by Region (2027-2032) Table 51. Global Mesalazine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Mesalazine Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Mesalazine Sales Value Share by Region (2021-2026) Table 54. Global Mesalazine Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Mesalazine Sales Value Share by Region (2027-2032) Table 56. Global Mesalazine Market Average Price (US$/Kg) by Region (2021-2026) Table 57. Global Mesalazine Market Average Price (US$/Kg) by Region (2027-2032) Table 58. Global Mesalazine Sales by Country: 2021 VS 2025 VS 2032 (Ton) Table 59. Global Mesalazine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Mesalazine Sales by Country (2021-2026) & (Ton) Table 61. Global Mesalazine Sales Market Share by Country (2021-2026) Table 62. Global Mesalazine Sales by Country (2027-2032) & (Ton) Table 63. Global Mesalazine Sales Market Share by Country (2027-2032) Table 64. Global Mesalazine Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Mesalazine Sales Value Market Share by Country (2021-2026) Table 66. Global Mesalazine Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Mesalazine Sales Value Market Share by Country (2027-2032) Table 68. PharmaZell Company Information Table 69. PharmaZell Business Overview Table 70. PharmaZell Mesalazine Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 71. PharmaZell Mesalazine Product Portfolio Table 72. PharmaZell Recent Development Table 73. Syntese A/S Company Information Table 74. Syntese A/S Business Overview Table 75. Syntese A/S Mesalazine Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 76. Syntese A/S Mesalazine Product Portfolio Table 77. Syntese A/S Recent Development Table 78. Cambrex Corporation Company Information Table 79. Cambrex Corporation Business Overview Table 80. Cambrex Corporation Mesalazine Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 81. Cambrex Corporation Mesalazine Product Portfolio Table 82. Cambrex Corporation Recent Development Table 83. Divis Laboratories Company Information Table 84. Divis Laboratories Business Overview Table 85. Divis Laboratories Mesalazine Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 86. Divis Laboratories Mesalazine Product Portfolio Table 87. Divis Laboratories Recent Development Table 88. Chemi SpA Company Information Table 89. Chemi SpA Business Overview Table 90. Chemi SpA Mesalazine Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 91. Chemi SpA Mesalazine Product Portfolio Table 92. Chemi SpA Recent Development Table 93. Ipca Laboratories Company Information Table 94. Ipca Laboratories Business Overview Table 95. Ipca Laboratories Mesalazine Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 96. Ipca Laboratories Mesalazine Product Portfolio Table 97. Ipca Laboratories Recent Development Table 98. Hangzhou Brother Company Information Table 99. Hangzhou Brother Business Overview Table 100. Hangzhou Brother Mesalazine Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 101. Hangzhou Brother Mesalazine Product Portfolio Table 102. Hangzhou Brother Recent Development Table 103. Lianyungang Fengheng Biopharm Company Information Table 104. Lianyungang Fengheng Biopharm Business Overview Table 105. Lianyungang Fengheng Biopharm Mesalazine Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 106. Lianyungang Fengheng Biopharm Mesalazine Product Portfolio Table 107. Lianyungang Fengheng Biopharm Recent Development Table 108. Lasa Loboratory Company Information Table 109. Lasa Loboratory Business Overview Table 110. Lasa Loboratory Mesalazine Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 111. Lasa Loboratory Mesalazine Product Portfolio Table 112. Lasa Loboratory Recent Development Table 113. Corden Pharma Bergamo Company Information Table 114. Corden Pharma Bergamo Business Overview Table 115. Corden Pharma Bergamo Mesalazine Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 116. Corden Pharma Bergamo Mesalazine Product Portfolio Table 117. Corden Pharma Bergamo Recent Development Table 118. Erregierre SpA Company Information Table 119. Erregierre SpA Business Overview Table 120. Erregierre SpA Mesalazine Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 121. Erregierre SpA Mesalazine Product Portfolio Table 122. Erregierre SpA Recent Development Table 123. CTX Lifescience Company Information Table 124. CTX Lifescience Business Overview Table 125. CTX Lifescience Mesalazine Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 126. CTX Lifescience Mesalazine Product Portfolio Table 127. CTX Lifescience Recent Development Table 128. Ishita Active Pharma Ingredients Company Information Table 129. Ishita Active Pharma Ingredients Business Overview Table 130. Ishita Active Pharma Ingredients Mesalazine Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 131. Ishita Active Pharma Ingredients Mesalazine Product Portfolio Table 132. Ishita Active Pharma Ingredients Recent Development Table 133. YC Biotech (Jiangsu) Company Information Table 134. YC Biotech (Jiangsu) Business Overview Table 135. YC Biotech (Jiangsu) Mesalazine Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 136. YC Biotech (Jiangsu) Mesalazine Product Portfolio Table 137. YC Biotech (Jiangsu) Recent Development Table 138. Xinxiang Tianfeng Fine Chemical Company Information Table 139. Xinxiang Tianfeng Fine Chemical Business Overview Table 140. Xinxiang Tianfeng Fine Chemical Mesalazine Sales (Ton), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 141. Xinxiang Tianfeng Fine Chemical Mesalazine Product Portfolio Table 142. Xinxiang Tianfeng Fine Chemical Recent Development Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. Mesalazine Distributors List Table 146. Mesalazine Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Mesalazine Product Image Figure 2. Global Mesalazine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mesalazine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Mesalazine Sales (2021-2032) & (Ton) Figure 5. Global Mesalazine Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global Mesalazine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Above 97 % Image Figure 10. Above 98 % Image Figure 11. Above 99 % Image Figure 12. Global Mesalazine Sales Volume by Type (2021 VS 2025 VS 2032) & (Ton) Figure 13. Global Mesalazine Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Mesalazine Sales Volume Share by Type (2021-2032) Figure 15. Global Mesalazine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Mesalazine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Mesalazine Sales Value Share by Type (2021-2032) Figure 18. Tablets Image Figure 19. Capsules Image Figure 20. Pellet and Granule Image Figure 21. Suppository Image Figure 22. Enema Image Figure 23. Others Image Figure 24. Global Mesalazine Sales Volume by Application (2021 VS 2025 VS 2032) & (Ton) Figure 25. Global Mesalazine Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Mesalazine Sales Volume Share by Application (2021-2032) Figure 27. Global Mesalazine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Mesalazine Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Mesalazine Sales Value Share by Application (2021-2032) Figure 30. Global Mesalazine Sales by Region: 2021 VS 2025 VS 2032 (Ton) Figure 31. Global Mesalazine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Mesalazine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Mesalazine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Mesalazine Sales Value (2021-2032) & (US$ Million) Figure 35. North America Mesalazine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Mesalazine Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Mesalazine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Mesalazine Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Mesalazine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Mesalazine Sales Value (2021-2032) & (US$ Million) Figure 41. South America Mesalazine Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Mesalazine Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Mesalazine Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Mesalazine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Mesalazine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Mesalazine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Mesalazine Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Mesalazine Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Above 97 %
  • Above 98 %
  • Above 99 %
Applications
  • Tablets
  • Capsules
  • Pellet and Granule
  • Suppository
  • Enema
  • Others
Companies covered
  • PharmaZell
  • Syntese A/S
  • Cambrex Corporation
  • Divis Laboratories
  • Chemi SpA
  • Ipca Laboratories
  • Hangzhou Brother
  • Lianyungang Fengheng Biopharm
  • Lasa Loboratory
  • Corden Pharma Bergamo
  • Erregierre SpA
  • CTX Lifescience
  • Ishita Active Pharma Ingredients
  • YC Biotech (Jiangsu)
  • Xinxiang Tianfeng Fine Chemical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mesalazine Sales Value (2021-2032)
  4. 1.2.2 Global Mesalazine Sales Volume (2021-2032)
  5. 1.2.3 Global Mesalazine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Mesalazine Market Dynamics
  1. 2.1 Mesalazine Industry Trends
  2. 2.2 Mesalazine Industry Drivers
  3. 2.3 Mesalazine Industry Opportunities and Challenges
  4. 2.4 Mesalazine Industry Restraints
3 Mesalazine Market by Company
  1. 3.1 Global Mesalazine Company Revenue Ranking in 2025
  2. 3.2 Global Mesalazine Revenue by Company (2021-2026)
  3. 3.3 Global Mesalazine Sales Volume by Company (2021-2026)
  4. 3.4 Global Mesalazine Average Price by Company (2021-2026)
  5. 3.5 Global Mesalazine Company Ranking (2024-2026)
  6. 3.6 Global Mesalazine Company Manufacturing Base and Headquarters
  7. 3.7 Global Mesalazine Company Product Type and Application
  8. 3.8 Global Mesalazine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Mesalazine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Mesalazine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Mesalazine Market by Type
  1. 4.1 Mesalazine Type Introduction
  2. 4.1.1 Above 97 %
  3. 4.1.2 Above 98 %
  4. 4.1.3 Above 99 %
  5. 4.2 Global Mesalazine Sales Volume by Type
  6. 4.2.1 Global Mesalazine Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Mesalazine Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Mesalazine Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Mesalazine Sales Value by Type
  10. 4.3.1 Global Mesalazine Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Mesalazine Sales Value by Type (2021-2032)
  12. 4.3.3 Global Mesalazine Sales Value Share by Type (2021-2032)
5 Mesalazine Market by Application
  1. 5.1 Mesalazine Application Introduction
  2. 5.1.1 Tablets
  3. 5.1.2 Capsules
  4. 5.1.3 Pellet and Granule
  5. 5.1.4 Suppository
  6. 5.1.5 Enema
  7. 5.1.6 Others
  8. 5.2 Global Mesalazine Sales Volume by Application
  9. 5.2.1 Global Mesalazine Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Mesalazine Sales Volume by Application (2021-2032)
  11. 5.2.3 Global Mesalazine Sales Volume Share by Application (2021-2032)
  12. 5.3 Global Mesalazine Sales Value by Application
  13. 5.3.1 Global Mesalazine Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Mesalazine Sales Value by Application (2021-2032)
  15. 5.3.3 Global Mesalazine Sales Value Share by Application (2021-2032)
6 Mesalazine Regional Sales and Value Analysis
  1. 6.1 Global Mesalazine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mesalazine Sales by Region (2021-2032)
  3. 6.2.1 Global Mesalazine Sales by Region: 2021-2026
  4. 6.2.2 Global Mesalazine Sales by Region (2027-2032)
  5. 6.3 Global Mesalazine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Mesalazine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Mesalazine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Mesalazine Sales Value by Region (2027-2032)
  9. 6.5 Global Mesalazine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Mesalazine Sales Value (2021-2032)
  12. 6.6.2 North America Mesalazine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Mesalazine Sales Value (2021-2032)
  15. 6.7.2 Europe Mesalazine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Mesalazine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Mesalazine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Mesalazine Sales Value (2021-2032)
  21. 6.9.2 South America Mesalazine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Mesalazine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Mesalazine Sales Value Share by Country, 2025 VS 2032
7 Mesalazine Country-level Sales and Value Analysis
  1. 7.1 Global Mesalazine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Mesalazine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Mesalazine Sales by Country (2021-2032)
  4. 7.3.1 Global Mesalazine Sales by Country (2021-2026)
  5. 7.3.2 Global Mesalazine Sales by Country (2027-2032)
  6. 7.4 Global Mesalazine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Mesalazine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Mesalazine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Mesalazine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Mesalazine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Mesalazine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Mesalazine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Mesalazine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Mesalazine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Mesalazine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Mesalazine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Mesalazine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Mesalazine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Mesalazine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Mesalazine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Mesalazine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Mesalazine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Mesalazine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Mesalazine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Mesalazine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Mesalazine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Mesalazine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Mesalazine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Mesalazine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Mesalazine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Mesalazine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Mesalazine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Mesalazine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Mesalazine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Mesalazine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Mesalazine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Mesalazine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Mesalazine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Mesalazine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Mesalazine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Mesalazine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Mesalazine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Mesalazine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Mesalazine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Mesalazine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Mesalazine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Mesalazine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Mesalazine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Mesalazine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Mesalazine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Mesalazine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Mesalazine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Mesalazine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Mesalazine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Mesalazine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Mesalazine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Mesalazine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Mesalazine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Mesalazine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Mesalazine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Mesalazine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Mesalazine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Mesalazine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Mesalazine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Mesalazine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Mesalazine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Mesalazine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Mesalazine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Mesalazine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Mesalazine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Mesalazine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Mesalazine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Mesalazine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Mesalazine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Mesalazine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Mesalazine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Mesalazine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Mesalazine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Mesalazine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Mesalazine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Mesalazine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Mesalazine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Mesalazine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Mesalazine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Mesalazine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Mesalazine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Mesalazine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Mesalazine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Mesalazine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Mesalazine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Mesalazine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Mesalazine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 PharmaZell
  2. 8.1.1 PharmaZell Company Information
  3. 8.1.2 PharmaZell Business Overview
  4. 8.1.3 PharmaZell Mesalazine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 PharmaZell Mesalazine Product Portfolio
  6. 8.1.5 PharmaZell Recent Developments
  7. 8.2 Syntese A/S
  8. 8.2.1 Syntese A/S Company Information
  9. 8.2.2 Syntese A/S Business Overview
  10. 8.2.3 Syntese A/S Mesalazine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Syntese A/S Mesalazine Product Portfolio
  12. 8.2.5 Syntese A/S Recent Developments
  13. 8.3 Cambrex Corporation
  14. 8.3.1 Cambrex Corporation Company Information
  15. 8.3.2 Cambrex Corporation Business Overview
  16. 8.3.3 Cambrex Corporation Mesalazine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cambrex Corporation Mesalazine Product Portfolio
  18. 8.3.5 Cambrex Corporation Recent Developments
  19. 8.4 Divis Laboratories
  20. 8.4.1 Divis Laboratories Company Information
  21. 8.4.2 Divis Laboratories Business Overview
  22. 8.4.3 Divis Laboratories Mesalazine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Divis Laboratories Mesalazine Product Portfolio
  24. 8.4.5 Divis Laboratories Recent Developments
  25. 8.5 Chemi SpA
  26. 8.5.1 Chemi SpA Company Information
  27. 8.5.2 Chemi SpA Business Overview
  28. 8.5.3 Chemi SpA Mesalazine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Chemi SpA Mesalazine Product Portfolio
  30. 8.5.5 Chemi SpA Recent Developments
  31. 8.6 Ipca Laboratories
  32. 8.6.1 Ipca Laboratories Company Information
  33. 8.6.2 Ipca Laboratories Business Overview
  34. 8.6.3 Ipca Laboratories Mesalazine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Ipca Laboratories Mesalazine Product Portfolio
  36. 8.6.5 Ipca Laboratories Recent Developments
  37. 8.7 Hangzhou Brother
  38. 8.7.1 Hangzhou Brother Company Information
  39. 8.7.2 Hangzhou Brother Business Overview
  40. 8.7.3 Hangzhou Brother Mesalazine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hangzhou Brother Mesalazine Product Portfolio
  42. 8.7.5 Hangzhou Brother Recent Developments
  43. 8.8 Lianyungang Fengheng Biopharm
  44. 8.8.1 Lianyungang Fengheng Biopharm Company Information
  45. 8.8.2 Lianyungang Fengheng Biopharm Business Overview
  46. 8.8.3 Lianyungang Fengheng Biopharm Mesalazine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Lianyungang Fengheng Biopharm Mesalazine Product Portfolio
  48. 8.8.5 Lianyungang Fengheng Biopharm Recent Developments
  49. 8.9 Lasa Loboratory
  50. 8.9.1 Lasa Loboratory Company Information
  51. 8.9.2 Lasa Loboratory Business Overview
  52. 8.9.3 Lasa Loboratory Mesalazine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Lasa Loboratory Mesalazine Product Portfolio
  54. 8.9.5 Lasa Loboratory Recent Developments
  55. 8.10 Corden Pharma Bergamo
  56. 8.10.1 Corden Pharma Bergamo Company Information
  57. 8.10.2 Corden Pharma Bergamo Business Overview
  58. 8.10.3 Corden Pharma Bergamo Mesalazine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Corden Pharma Bergamo Mesalazine Product Portfolio
  60. 8.10.5 Corden Pharma Bergamo Recent Developments
  61. 8.11 Erregierre SpA
  62. 8.11.1 Erregierre SpA Company Information
  63. 8.11.2 Erregierre SpA Business Overview
  64. 8.11.3 Erregierre SpA Mesalazine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Erregierre SpA Mesalazine Product Portfolio
  66. 8.11.5 Erregierre SpA Recent Developments
  67. 8.12 CTX Lifescience
  68. 8.12.1 CTX Lifescience Company Information
  69. 8.12.2 CTX Lifescience Business Overview
  70. 8.12.3 CTX Lifescience Mesalazine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 CTX Lifescience Mesalazine Product Portfolio
  72. 8.12.5 CTX Lifescience Recent Developments
  73. 8.13 Ishita Active Pharma Ingredients
  74. 8.13.1 Ishita Active Pharma Ingredients Company Information
  75. 8.13.2 Ishita Active Pharma Ingredients Business Overview
  76. 8.13.3 Ishita Active Pharma Ingredients Mesalazine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Ishita Active Pharma Ingredients Mesalazine Product Portfolio
  78. 8.13.5 Ishita Active Pharma Ingredients Recent Developments
  79. 8.14 YC Biotech (Jiangsu)
  80. 8.14.1 YC Biotech (Jiangsu) Company Information
  81. 8.14.2 YC Biotech (Jiangsu) Business Overview
  82. 8.14.3 YC Biotech (Jiangsu) Mesalazine Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 YC Biotech (Jiangsu) Mesalazine Product Portfolio
  84. 8.14.5 YC Biotech (Jiangsu) Recent Developments
  85. 8.15 Xinxiang Tianfeng Fine Chemical
  86. 8.15.1 Xinxiang Tianfeng Fine Chemical Company Information
  87. 8.15.2 Xinxiang Tianfeng Fine Chemical Business Overview
  88. 8.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Xinxiang Tianfeng Fine Chemical Mesalazine Product Portfolio
  90. 8.15.5 Xinxiang Tianfeng Fine Chemical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mesalazine Value Chain Analysis
  2. 9.1.1 Mesalazine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mesalazine Sales Mode & Process
  6. 9.2 Mesalazine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mesalazine Distributors
  9. 9.2.3 Mesalazine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst